UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000031686
Receipt No. R000036188
Scientific Title The effects of peroral administration of Tofogliflozin(SGLT2 inhibitor) on endogenous glucose production and insulin clearance, single effet and chronic effect.
Date of disclosure of the study information 2018/03/16
Last modified on 2019/06/13 21:45:36

No. Disposal Last modified on Item of update
1 Insert 2018/03/12 17:46:57
2 Update 2018/03/14 16:39:06 Public title
Acronym
3 Update 2018/03/14 16:42:15 Public title
Public title
4 Update 2018/03/14 16:46:12 Genomic information
Narrative objectives1
5 Update 2018/03/14 16:54:25 Narrative objectives1
6 Update 2018/03/14 16:57:44 Public title
Public title
7 Update 2018/03/14 17:05:47 Narrative objectives1
Primary outcomes
Key secondary outcomes
8 Update 2018/03/14 17:37:47 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
9 Update 2018/03/14 17:40:00 Email1
10 Update 2018/03/16 10:22:33 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
11 Update 2018/03/16 11:18:18 Interventions/Control_1
Interventions/Control_1
12 Update 2018/12/10 09:49:48 Recruitment status
13 Update 2019/06/13 21:45:36 Recruitment status
Date of IRB
Last follow-up date
Other related information


Contact us.